The Economic of Denials Claims Reimbursement Friction
By Dalton Han, Co-Founder, Red Sky Health
LinkedIn: Dalton Han
LinkedIn: Red Sky Health
The easiest way to misunderstand health insurance denials is to count them once and move on. For years, healthcare organizations have treated denials as an administrative metric, a back-office measure reviewed by revenue cycle teams and reported through operational dashboards. But today’s reimbursement environment tells a far more consequential story. Claims denials have become one of the clearest indicators of how administrative complexity, payer leverage, and financial pressure are reshaping the economics of care delivery.
The problem is not that denials exist. The problem is that many organizations continue to measure them in ways that obscure their true financial impact.
Denial rates, appeal volumes, and resolution activity remain important operational metrics. Yet, they were designed to measure workflow performance, not revenue performance. As reimbursement has become more complex, healthcare organizations have continued relying on metrics that often provide only a partial view of the financial outcomes that matter most. As a result, many leaders may believe they have visibility into denial performance while significant revenue loss remains hidden beneath the surface.
The Claim Denials Visibility Problem
At the heart of the issue is a simple distinction: operational outcomes and financial outcomes are not the same thing. Revenue cycle teams routinely decide which denials to pursue and which to abandon. Many denied claims are technically recoverable, but not economically viable. When the cost of documentation, clinical review, administrative follow-up, and appeals exceeds the expected reimbursement, organizations often write off the claim and move on.
Viewed individually, these decisions are rational. Viewed collectively, they can create substantial revenue leakage. The challenge is that most denial reporting frameworks provide little visibility into what happens after a denial occurs. How much revenue was ultimately recovered? How much was delayed? How much was underpaid, abandoned, or written off? These questions often receive less attention than the denial event itself. Without that broader perspective, leaders risk mistaking operational activity for financial performance.
Why Traditional Claim Denial Metrics Are Less Reliable
The limitations of traditional denial metrics become more pronounced as reimbursement complexity increases. For years, denials were often framed as a provider-side efficiency issue. The prevailing assumption was that cleaner workflows, stronger documentation practices, and better front-end controls would reduce reimbursement friction. While those capabilities remain important, they explain only part of the challenge.
Healthcare reimbursement now operates through an increasingly complex ecosystem of payer-specific edits, prior authorization requirements, coding rules, modifier logic, medical necessity reviews, and claim-line adjudication processes. A single patient encounter may pass through dozens of decision points before reimbursement is finalized.
This complexity creates a measurement problem. A claim can be classified as paid while individual service lines within that claim are denied, downcoded, bundled, or reimbursed below expectation. Operationally, the claim appears resolved. Financially, revenue has still been lost. As reimbursement friction becomes embedded throughout the payment process, denial rates alone become a less reliable indicator of financial performance. The critical question is no longer how many claims were denied, but how much revenue was ultimately realized, delayed, reduced, or lost because of the reimbursement process itself.
The Hidden Economics of Reimbursement Friction
The financial consequences of this measurement gap are significant. A 2025 Health Affairs analysis summarized by the American Hospital Association found that Medicare Advantage plans denied approximately 17% of initial claims, with 57% of those denials eventually overturned. Yet providers still experienced an estimated 7% net revenue loss because not all denied claims were fully recovered.
The finding highlights a common misconception. A high overturn rate is often presented as evidence that the reimbursement system works when, in reality, a denial that is reversed months later still carries a cost. Revenue is delayed, administrative resources are consumed, and working capital remains tied up throughout the recovery process. From a financial perspective, reimbursement delayed by 60 or 90 days affects far more than collections. It influences liquidity planning, staffing decisions, capital allocation, and an organization’s ability to invest in future growth. In effect, providers frequently become involuntary financiers of reimbursement friction.
How AI is Leveling Claims Denial Management
The burden of reimbursement friction is not distributed evenly. Behavioral health organizations, specialty providers, rural health systems, and post-acute facilities often face some of the highest administrative demands while operating with more limited staffing and financial resources. Providers serving lower-income populations frequently encounter additional reimbursement challenges, further increasing the cost of navigating the claims process.
The result is a reimbursement environment that increasingly rewards scale. Larger organizations are generally better positioned to absorb delays, invest in specialized revenue cycle teams, and manage growing administrative complexity. Smaller providers often have far less margin for error.
Artificial intelligence is poised to amplify this dynamic. For providers, AI offers new opportunities to improve denial prediction, strengthen documentation quality, prioritize appeals, and focus resources on the claims most likely to be recovered. At the same time, payers have already moved aggressively toward automation. According to the National Association of Insurance Commissioners, 84% of surveyed insurers report using artificial intelligence or machine learning in functions that include prior authorization and claims review.
As reimbursement decisions increasingly occur at machine speed, denial management can no longer be viewed solely as a back-office function. It must be a strategic capability that directly influences cash flow, margin performance, workforce productivity, and organizational resilience. The organizations that outperform in this environment will not necessarily be those with the lowest denial rates. They will be those that understand the economics of reimbursement friction more clearly than their competitors and allocate resources accordingly.
The KPIs Healthcare Leaders Should Be Watching
If denials are treated as a financial performance issue, traditional denial-rate reporting alone no longer provides enough insight. Healthcare leaders need KPIs that reveal the true economic impact of reimbursement friction across the entire claims lifecycle, including:
- First-Pass Denial Rate: The percentage of unique CPT codes denied upon initial submission.
- Denial Resubmission Rate: The percentage of initially denied CPT codes that are resubmitted for reconsideration.
- Resubmission Success Rate: The percentage of resubmitted denied CPT codes that ultimately receive payment.
- Denial Recovery Rate: The percentage of the original denied claim value that is eventually recovered through reimbursement.
These metrics move the conversation beyond “How many denials occurred?” and toward the more meaningful question: “How much financial value was lost, delayed, or recovered because of reimbursement friction?”
The larger takeaway is one healthcare organizations can no longer afford to overlook: denials are actually a visibility and measurement issue. Many providers continue losing revenue because their denial-tracking systems create the appearance of transparency while failing to capture the full financial consequences beneath the surface. Even denials that are later overturned carry significant operational costs. They consume staff time, delay cash flow, strain administrative resources, and erode margins. In many cases, the delay itself becomes a measurable financial loss.
Today’s claims-remediation challenge extends far beyond reducing denial percentages. The real objective is understanding the complete economics of reimbursement friction, from initial adjudication and appeals through recovery, abandonment, and final resolution. Until healthcare organizations measure the entire denial lifecycle rather than isolated rejection events, they risk optimizing dashboards while recoverable revenue continues to disappear unnoticed.
More sophisticated KPIs will not eliminate the complexity of modern medical billing. But they can make that complexity visible, measurable, and manageable. And in today’s reimbursement environment, visibility is the foundation of financial control.